Cargando…
RET融合型非小细胞肺癌的研究进展
In the past 20 years, with the development of molecular biology, the treatment of non-small cell lung cancer (NSCLC) has been developing. Targeted therapy has improved the survival period of patients with positive mutation of tumor driver gene. More and more targets have been found gradually. Drugs...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387645/ https://www.ncbi.nlm.nih.gov/pubmed/34120433 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.22 |